UBS Group AG - AYALA PHARMACEUTICALS INC ownership

AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 16 filers reported holding AYALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AYALA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$404
-86.5%
1,010
-59.4%
0.00%
Q2 2022$3,000
-40.0%
2,488
+477.3%
0.00%
Q3 2021$5,000
-91.1%
431
-92.2%
0.00%
Q2 2021$56,000
+330.8%
5,509
+372.1%
0.00%
Q1 2021$13,000
+1200.0%
1,167
+1154.8%
0.00%
Q4 2020$1,000
-80.0%
93
-77.7%
0.00%
Q3 2020$5,0004170.00%
Other shareholders
AYALA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 489,988$5,346,0001.08%
Opaleye Management Inc. 108,551$1,184,0000.17%
Redmile Group, LLC 667,816$7,286,0000.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,000$382,0000.01%
Chevy Chase Trust Holdings, LLC 15,000$164,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 709,048$7,736,0000.00%
MORGAN STANLEY 4,173$46,0000.00%
Tower Research Capital LLC (TRC) 1,742$19,0000.00%
ROYAL BANK OF CANADA 1,250$14,0000.00%
UBS Group AG 1,167$13,0000.00%
View complete list of AYALA PHARMACEUTICALS INC shareholders